Toho-1 β-lactamase: backbone chemical shift assignments and changes in dynamics upon binding with avibactam

Author(s):  
Varun V. Sakhrani ◽  
Rittik K. Ghosh ◽  
Eduardo Hilario ◽  
Kevin L. Weiss ◽  
Leighton Coates ◽  
...  
2015 ◽  
Vol 9 (2) ◽  
pp. 381-385 ◽  
Author(s):  
Garry W. Buchko ◽  
Thomas E. Edwards ◽  
Stephen N. Hewitt ◽  
Isabelle Q. H. Phan ◽  
Wesley C. Van Voorhis ◽  
...  

2012 ◽  
Vol 7 (1) ◽  
pp. 21-24 ◽  
Author(s):  
Aurélien Lorin ◽  
Danny Létourneau ◽  
Andrée Lefebvre ◽  
Jean-Guy LeHoux ◽  
Pierre Lavigne

2010 ◽  
Vol 4 (1) ◽  
pp. 97-99 ◽  
Author(s):  
Yonghong Zhang ◽  
Chelsea K. Thornburg ◽  
H. Scott Stadler ◽  
James B. Ames

Author(s):  
Sophie M. Korn ◽  
Roderick Lambertz ◽  
Boris Fürtig ◽  
Martin Hengesbach ◽  
Frank Löhr ◽  
...  

AbstractThe current outbreak of the highly infectious COVID-19 respiratory disease is caused by the novel coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). To fight the pandemic, the search for promising viral drug targets has become a cross-border common goal of the international biomedical research community. Within the international Covid19-NMR consortium, scientists support drug development against SARS-CoV-2 by providing publicly available NMR data on viral proteins and RNAs. The coronavirus nucleocapsid protein (N protein) is an RNA-binding protein involved in viral transcription and replication. Its primary function is the packaging of the viral RNA genome. The highly conserved architecture of the coronavirus N protein consists of an N-terminal RNA-binding domain (NTD), followed by an intrinsically disordered Serine/Arginine (SR)-rich linker and a C-terminal dimerization domain (CTD). Besides its involvement in oligomerization, the CTD of the N protein (N-CTD) is also able to bind to nucleic acids by itself, independent of the NTD. Here, we report the near-complete NMR backbone chemical shift assignments of the SARS-CoV-2 N-CTD to provide the basis for downstream applications, in particular site-resolved drug binding studies.


2016 ◽  
Vol 11 (1) ◽  
pp. 51-56 ◽  
Author(s):  
Garry W. Buchko ◽  
Matthew C. Clifton ◽  
Ellen G. Wallace ◽  
Kateri A. Atkins ◽  
Peter J. Myler

2017 ◽  
Vol 11 (1) ◽  
pp. 117-121 ◽  
Author(s):  
Remy Sounier ◽  
Yinshan Yang ◽  
Joanna Hagelberger ◽  
Sébastien Granier ◽  
Hélène Déméné

Author(s):  
Serafima Guseva ◽  
Laura Mariño Perez ◽  
Aldo Camacho-Zarco ◽  
Luiza Mamigonian Bessa ◽  
Nicola Salvi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document